IGA NEPHROPATHY
Clinical trials for IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney disease: atrasentan shows promise in IgA nephropathy trial
Disease control CompletedThis study tested a drug called atrasentan in 54 adults with IgA nephropathy, a kidney disease. Participants were already on standard treatments, including SGLT2 inhibitors. The goal was to see if atrasentan could further reduce protein in the urine, a sign of kidney damage, comp…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 04:01 UTC
-
New drug targets kidney disease in early trial
Disease control CompletedThis study tested a new drug called ARO-C3 in healthy volunteers and people with kidney diseases caused by an overactive immune system (C3 Glomerulopathy and IgA Nephropathy). The main goal was to check the drug's safety and how it moves through the body. Participants received on…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:57 UTC
-
New pill shows promise in slowing rare kidney disease
Disease control CompletedThis study tested a drug called iptacopan (LNP023) in 518 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants took either the drug or a placebo alongside their usual care. The goal was to see if iptacopan could reduce protein in the urine a…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:57 UTC
-
Can early steroids save kidneys in IgA nephropathy?
Disease control CompletedThis study looked at whether adding early steroid treatment to standard blood pressure medication helps people with IgA nephropathy who have severe kidney damage. 62 adults took part. The goal was to see if the combination could prevent kidney function from getting worse over two…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 03:54 UTC
-
New hope for kidney disease: drug trial targets IgA nephropathy
Disease control CompletedThis study tested an experimental drug called HR19042 in 316 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug can reduce protein in the urine and protect kidney function better than a placebo. Participants took capsules for a period, and researchers …
Matched conditions: IGA NEPHROPATHY
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:38 UTC